|
Volumn 11, Issue 17, 2001, Pages 2235-2239
|
Evolution of anti-HIV drug candidates. Part 3: Diarylpyrimidine (DAPY) analogues
a a a a a a a b c c c b b b b b b d d b
c
Virco BVBA
(Belgium)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 (4 CYANOANILINO) 4 (2,4,6 TRIMETHYLANILINO)PYRIMIDINE;
DELAVIRDINE;
EFAVIRENZ;
NEVIRAPINE;
PYRIMIDINE DERIVATIVE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
UNCLASSIFIED DRUG;
ARTICLE;
DRUG ACTIVITY;
DRUG POTENCY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
NONHUMAN;
VIRUS INHIBITION;
VIRUS MUTANT;
ANTI-HIV AGENTS;
DRUG EVALUATION, PRECLINICAL;
HIV-1;
HIV-1 REVERSE TRANSCRIPTASE;
INHIBITORY CONCENTRATION 50;
MUTATION;
NITRILES;
PYRIMIDINES;
REVERSE TRANSCRIPTASE INHIBITORS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 17944374798
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(01)00412-7 Document Type: Article |
Times cited : (205)
|
References (17)
|